- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
ZEPP
NYSE
Week ended 24 Jul 2026
Weekly Investor Report
Zepp Health Corp · Technology · Consumer Electronics
Latest close
4.90 USD
-9.3%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -64.9% below the Trend Line and sits at 1.8% of its 52-week range. The latest completed week returned -9.3%, after a 9.1% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 57/100 conviction, while the latest news-sentiment score is 49/100. Near-term considerations: volume confirmation is below normal; earnings are due in 4d.
Setup score
14
out of 100
Latest Close
4.90 USD
24 Jul 2026
1W Return
-9.3%
latest completed week
4W Return
9.1%
short-term follow-through
12W Return
-73.4%
quarterly tape
Trend Breadth
40.4%
21 of 52 weeks active
Volume Ratio
0.3x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-9.3%
Latest completed week; four-week move 9.1%.
Indicator stack
22/28
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 44.71%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
Options pressure
Volatility
57/100 conviction; expected move 27.6%.
News sentiment
49/100
45 relevant articles in the latest sentiment read.
Event risk
4d
Next report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -64.9% below the Trend Line and sits at 1.8% of its 52-week range. The latest completed week returned -9.3%, after a 9.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.3x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0112-week average 0.02
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.01Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 9.1% over four weeks, -73.4% over 12 weeks, and -56.0% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year21
Trend breadth40.4%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-1.12Latest activity-pressure read.
Pressure change-23.8%Four-week change in activity pressure.
Leadership-81.07Latest relative-leadership reading.
RS change2.0%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive.
Factor week 26 Jul 2026
Financial statements through 31 Dec 2025
Field coverage 82%
Model confidence 78%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength36/100Blend of value, momentum, and quality. Underlying universe rank 65; rank 1 is best.
Value80/100Relative valuation strength. Underlying universe rank 21; rank 1 is best.
Quality9/100Profitability and accounting quality. Underlying universe rank 92; rank 1 is best.
Momentum4/100Medium-term price momentum. Underlying universe rank 97; rank 1 is best.
Growth86/100Revenue and earnings growth. Underlying universe rank 15; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 0.0x Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -17.2% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 38.7% Gross profit retained from each unit of revenue.
- Operating margin
- -10.1% Operating profit retained from revenue.
- Free-cash-flow margin
- -9.1% Free cash flow generated from revenue.
- Return on invested capital
- -6.4% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 47.1% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- 1.7% Net share repurchases relative to market value.
- Shareholder yield
- 1.7% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -4.6x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Options positioningVolatility
ZEPP shows volatility options pressure with a 57/100 conviction score, put-call volume ratio of 0.00, expected move of 27.6%, and Sharemaestro trend signal inactive.
Conviction57/100
Expected move27.6%
Put/call volume0.00
Insider activity-
No recent insider transactions are stored for this company.
News sentiment49/100
Weighted news tone is neutral across 45 relevant articles.
8 positive · 31 neutral · 6 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings4dNext report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
Options expected move27.6%Nearest-chain priced movement where available.
52-week drawdown-92.1%Distance below the 52-week high.
13-week volatility13.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
27 Mar
24 Apr
22 May
19 Jun
24 Jul
Weeks higher11 of 2615 weeks finished lower.
Best week+31.8%Week of 13 Feb.
Worst week-35.6%Week of 20 Mar.
Latest week-9.3%Week of 24 Jul.
Shape of recent returns
Strong gains8
Modest gains3
Flat weeks0
Modest losses1
Sharp losses14
Recent vol13.7%13-week weekly-return volatility.
Base vol19.7%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew14.6% / -12.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Technology
4-week rank- / 100
Group average-5.0%
Trend breadth63.0%
Trend63.0%active weekly trend signals
MD49.0%positive activity pressure
RS54.0%positive relative leadership
Four-week leaders
IndustryUS Consumer Electronics
4-week rank2 / 14
Group average-8.7%
Trend breadth14.3%
Trend14.3%active weekly trend signals
MD42.9%positive activity pressure
RS7.1%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape17/100
Trend, activity pressure, participation, and risk combine to a 17/100 tape read.
Indicator analysis9/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.01; No reversal markers Next-Week ExpectancyNegative 44.71%Next-week expectancy is negative with a 44.71% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors31/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Tiny Titans rank 73; Buyback Yield rank 25; Small Cap Core rank 19 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Options37/100ZEPP shows volatility options pressure with a 57/100 conviction score, put-call volume ratio of 0.00, expected move of 27.6%, and Sharemaestro trend signal inactive.
Volatility · Volatility expansion watch · Expected move 27.6% Sentiment49/100Weighted news tone is neutral across 45 relevant articles.
Zepp Health Corp (ZEPP) Financial Health: Profitability & Balance Sheet Analysis Insiders50/100No recent insider transaction evidence is stored.
Earnings4dNext report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 24 Jul 2026 | 4.90 USD | -9.3% | 13.97 USD | 10.40 USD | -1.12 | -81.07 | 176.4K | Off |
| 17 Jul 2026 | 5.40 USD | 1.1% | 14.75 USD | 10.40 USD | -1.05 | -79.39 | 163.3K | Off |
| 10 Jul 2026 | 5.34 USD | 4.9% | 15.50 USD | 10.39 USD | -1.05 | -80.09 | 176.4K | Off |
| 3 Jul 2026 | 5.09 USD | 13.4% | 16.27 USD | 10.39 USD | -0.97 | -80.86 | 204.0K | Off |
| 26 Jun 2026 | 4.49 USD | -7.0% | 17.05 USD | 10.39 USD | -0.90 | -82.73 | 444.1K | Off |
| 19 Jun 2026 | 4.83 USD | 3.0% | 17.80 USD | 10.39 USD | -0.87 | -81.85 | 795.1K | Off |
| 12 Jun 2026 | 4.69 USD | -24.2% | 18.53 USD | 10.38 USD | -0.83 | -82.19 | 1.8M | Off |
| 5 Jun 2026 | 6.19 USD | -24.1% | 19.17 USD | 10.38 USD | -0.68 | -76.32 | 1.2M | Off |
| 29 May 2026 | 8.16 USD | -5.3% | 19.88 USD | 10.37 USD | -0.56 | -69.50 | 422.9K | Off |
| 22 May 2026 | 8.62 USD | -15.9% | 20.95 USD | 10.35 USD | -0.33 | -67.19 | 480.2K | Off |
| 15 May 2026 | 10.25 USD | -17.1% | 22.04 USD | 10.32 USD | -0.18 | -60.50 | 927.5K | Off |
| 8 May 2026 | 12.37 USD | -32.9% | 23.41 USD | 10.29 USD | -0.27 | -51.98 | 506.0K | Off |
| 1 May 2026 | 18.43 USD | 10.0% | 24.61 USD | 10.25 USD | -0.45 | -26.28 | 168.8K | Off |
| 24 Apr 2026 | 16.76 USD | 2.6% | 25.66 USD | 10.16 USD | -0.75 | -31.53 | 231.5K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.